Cecilia Mathó

Recurrent Dissemination of SARS-CoV-2 Through the Uruguayan–Brazilian Border

L. Spangenberg, R. Fort, P. Smircich, 2021, Frontiers in Microbiology.

VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.

P. Pennisi, M. Barontini, G. Sansó, 2016, Genetic testing and molecular biomarkers.

A clomazone immunoassay to study the environmental fate of the herbicide in rice (Oryza sativa) agriculture.

B. Hammock, M. Carlomagno, G. González-Sapienza, 2010, Journal of agricultural and food chemistry.

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions

E. Jonasch, Xian-de Liu, E. Coitiño, 2022, Frontiers in Endocrinology.

Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth

M. Méndez, E. Kimura, R. Fort, 2018, BMC Cancer.

An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer

R. Fort, B. Garat, J. Sotelo-Silveira, 2018, Experimental Hematology & Oncology.

Type 1 IGF Receptor Localization in Paediatric Gliomas: Significant Association with WHO Grading and Clinical Outcome

I. Bergadá, M. Lombardi, P. Pennisi, 2018, Hormones and Cancer.

Fibroblast deficiency of insulin-like growth factor 1 receptor type 1 (IGF1R) impairs initial steps of murine pheochromocytoma development.

P. Pennisi, C. Mathó, Ayelén Martín, 2019, Biochimie.

Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth

M. Méndez, E. Kimura, R. Fort, 2018, BMC Cancer.